Expression of thioredoxin-2 for monitoring minimal residual disease in acute leukemia / 中南大学学报(医学版)

ABSTRACT

OBJECTIVE@#To investigate the significance of human thioredoxin-2 (TRX-2) in monitoring minimal residual disease (MRD) in acute leukemia (AL).@*METHODS@#We used real-time quantitative PCR to serially quantitize TRX-2 expression levels in the bone marrow of AL patients at diagnosis (n=68), at complete hematologic remission (CHR, n=57) and at relapse (n=25). Another 25 normal donors served as normal controls. The upper limit of the bone marrow at 91 was regarded as the reference. TRX-2 expression level at CHR with 91). TRX-2 level was correlated to the expression level of MRD.@*CONCLUSION@#TRX-2 may be the marker for AL and used in MRD monitoring.